# US 2026/0083365 A1 · Method and system for detecting a bioanalyte in the blood

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083365 A1
- Document ID: US20260083365A1
- Status: Published application
- Kind: A1
- Application number: 19/106,655
- Filed: 2023-08-25
- Published: 2026-03-26
- Earliest claimed: 2022-08-26
- Assignees: Ramot at Tel-Aviv University Ltd.
- Applicants: Ramot at Tel-Aviv University Ltd.
- Inventors: Fernando PATOLSKY; Nimrod HARPAK; Ella BORBERG; Adva RAZ
- Web page: https://patentgrep.com/patent/US20260083365A1

## CPC

- A61B 5/14735: {comprising an immobilised reagent}
- A61M 37/0015: {by using microneedles}
- A61B 5/0002: {Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network (endoradiosondes A61B5/07)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/1473: invasive, e.g. introduced into the body by a catheter
- A61B 5/1486: using enzyme electrodes, e.g. with immobilised oxidase
- A61B 5/150022: {for capillary blood or interstitial fluid}
- A61B 5/150984: {Microneedles or microblades}
- A61B 5/157: {Devices} characterised by integrated means for measuring characteristics of blood
- A61B 5/685: {Microneedles}
- G01N 33/5438: {Electrodes}
- A61B 5/14514: {using means for aiding extraction of interstitial fluid, e.g. microneedles or suction}
- A61B 2562/0285: Nanoscale sensors
- A61M 2037/0046: {Solid microneedles}
- A61M 2037/0061: {Methods for using microneedles}
- A61M 2205/3303: Using a biosensor
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A microneedle device comprises a device structure, insertable to a living body and being formed with an opened niche at least partially surrounded by walls of micrometric heights above a base of the niche for allowing the niche to be filled with a blood sample upon the insertion. The device also comprises a biosensor configured to sense a bioanalyte in the blood sample and having a sensing element formed on the base. The thickness of the sensing element is less than the micrometric heights of the walls.

## Claims

### Claim 1

A microneedle device, comprising:
a device structure, insertable to a living body and being formed with an opened niche at least partially surrounded by walls of micrometric heights above a base of said niche for allowing said niche to be filled with a blood sample upon said insertion;
a biosensor configured to sense a bioanalyte in said blood sample and comprising a sensing element formed on said base and having a thickness less than said micrometric heights.

### Claim 2 (depends on 1)

The device of claim 1, comprising a plurality of biosensors each configured to sense a different bioanalyte in said blood sample.

### Claim 3 (depends on 2)

The device of claim 2, wherein said device structure is formed with a plurality of opened niches, and wherein sensing elements of at least two of said biosensors are on bases of different niches.

### Claim 4 (depends on 2)

The device of claim 2, wherein sensing elements of at least two of said biosensors are on a base of the same niche.

### Claim 5 (depends on 1)

The device of claim 1, comprising an inlet fluidic port at a section of said structure that remains outside said body after said insertion, and a fluidic channel extending from said inlet port to said niche, for establishing a flow of washing buffer into said niche in situ.

### Claim 6 (depends on 1)

The device of claim 1, comprising an electrical communication port in electrical communication with said biosensor for transmitting signal from said biosensor to a location outside said body, while said biosensor is inside said body.

### Claim 7 (depends on 1)

A device for monitoring at least presence of a bioanalyte, comprising a substrate having a skin contact surface, and a plurality of microneedle devices outwardly protruding from said skin contact surface, wherein at least one of said microneedle devices comprises the device of claim 1.

### Claim 8 (depends on 1)

The device of claim 1, wherein said bioanalyte comprises at least one of a protein, an miRNA, a free-DNA, an exosome, a metabolite, an antibody, and a receptor.

### Claim at position 9

9-14. (canceled)

### Claim 15 (depends on 1)

The device of claim 1, wherein said biosensor comprises a source electrode and a drain electrode formed on said base or said walls, and wherein said sensing element comprises a nanostructure having a sub-micrometric thickness connecting between said electrodes and being modified by an immobilized affinity moiety selected to interact with said bioanalyte to effect a change in an electrical property of said nanostructure.

### Claim 16 (depends on 15)

The device of claim 15, wherein said biosensor is a transistor and wherein said nanostructure is a channel of said transistor.

### Claim 17 (depends on 15)

The device of claim 15, wherein said affinity moiety comprises an immunogenic moiety.

### Claim 18 (depends on 17)

The device of claim 17, wherein said immunogenic moiety comprises at least one of (i) an antibody or a fragment thereof, and (ii) an antigen wherein said bioanalyte comprises an antibody to said antigen.

### Claim 19

(canceled)

### Claim 20 (depends on 15)

The device of claim 15, wherein said affinity moiety comprises a ligand and said bioanalyte comprises a receptor.

### Claim 21 (depends on 1)

A method of detecting a bioanalyte in the blood of a subject, the method comprising:
contacting the device of claim 1 with the blood of the subject in vivo;
extracting the device from the body of the subject; and
obtaining a signal from the biosensor thereby detecting a bioanalyte in the blood.

### Claim 22 (depends on 15)

A method of detecting a bioanalyte in the blood of a subject, the method comprising:
contacting the device of claim 15 with the blood of the subject in vivo;
extracting the device from the body of the subject;
washing said biosensor; and
detecting the bioanalyte based on a detectable signal received from said biosensor within a time-window beginning a predetermined time period after a beginning time of said washing.

### Claim 23 (depends on 5)

A method of detecting a bioanalyte in the blood of a subject, the method comprising:
contacting the device according to claim 5 with the blood of the subject in vivo;
washing said biosensor via said fluidic channel;
detecting the bioanalyte based on a detectable signal received from said biosensor within a time-window beginning a predetermined time period after a beginning time of said washing.

### Claim 24 (depends on 23)

The method according to claim 23, wherein said device comprises an electrical communication port in electrical communication with said biosensor for transmitting signal from said biosensor to a location outside said body, and wherein the method comprises receiving said signal via said electrical communication port while said biosensor is inside said body.

### Claim 25 (depends on 23)

The method according to claim 23, comprising extracting the device from the body of the subject, following said washing, and receiving said signal after said extraction.

### Claim 26 (depends on 22)

The method of claim 22, wherein said detecting comprises excluding from said signal any portion generated before said time-window.

### Claim 27 (depends on 22)

The method of claim 22, wherein said beginning of said time-window is defined at a time point at which a rate of change of said signal, in absolute value, is below a predetermined threshold.
